(-1a)

In Article 1, paragraph 5, point a is deleted; (1) In Article 2, point (8) is replaced by the following: “(8) ‘financial counterparty’means an investment firm authorised in accordance with Directive 2014/65/ EU of the European Parliament and of the Council (14), a credit institution authorised in accordance with Directive 2013/36/EU , an insurance or reinsurance undertaking authorised in accordance with Directive 2009/138/EC of the European Parliament and of the Council (15), a UCITS authorised in accordance with Directive 2009/65/EC except if that UCITS is related to an employee share purchase plan ,, an institution for occupational retirement provision within the meaning of Article 6(a) of Directive 2003/41/EC, an AIF as defined in Article 4(1)(a) of Directive 2011/61/EU, which is either established in the Union or managed by an alternative investment fund manager (AIFM) authorised or registered in accordance with Directive 2011/61/EU, except if that AIF is related to an employee share purchase plan, and, where relevant, its AIFM is established in the Union; and a central securities depository authorised in accordance with Regulation (EU) No 909/2014 of the European Parliament and of the Council (16) ▌;; (2) Article 4 is amended as follows: (a) In paragraph 1, point (a) is amended as follows: (i) points (i) to (iv) are replaced by the following: “(i) between two financial counterparties that are subject to the conditions in the second subparagraph of Article 4a(1); (ii) between a financial counterparty that is subject to the conditions in the second subparagraph of Article 4a(1) and a non-financial counterparty that is subject to the conditions in the second subparagraph of Article 10(1); (iii) between two non-financial counterparties that are subject to the conditions in the second subparagraph of Article 10(1); (iv) between, on the one hand, a financial counterparty that is subject to the conditions in the second subparagraph of Article 4a(1) or a non-financial counterparty that is subject to the conditions in the second subparagraph of Article 10(1), and, on the other hand, an entity established in a third country that would be subject to the clearing obligation if it were established in the Union;”; (b) in paragraph 1, point (b) is replaced by the following: “(b) they are entered into or novated either: (i) on or after the date from which the clearing obligation takes effect; or ii) on or after the date from which both counterparties meet the conditions set out in point (a). ”; (c) the following paragraphs are inserted: “3a. Clearing members and clients which provide clearing services, whether directly or indirectly, shall provide those services under fair, reasonable and non-discriminatory and transparent commercial terms. Such clearing members and clients shall take all reasonable steps designed to identify, prevent, manage and monitor conflicts of interest within a group of affiliated entities, in particular between the trading unit and the clearing unit, that may adversely affect the fair, reasonable, non-discriminatory and transparent provision of clearing services. Clearing members or clients shall be permitted to control the risks connected to the clearing services offered. 3b. In order to ensure the consistent application of this Article, ESMA shall develop draft regulatory technical standards specifying the conditions under which commercial terms for clearing services, referred to in paragraph 3a, are considered to be fair, reasonable, non-discriminatory and transparent. ESMA shall submit the draft regulatory technical standards referred to in the first subparagraph to the Commission by ... [six months following the date of entry into force of this amending Regulation]. The Commission is empowered to supplement this Regulation by adopting the regulatory technical standards referred to in the first subparagraph in accordance with Articles 10 to 14 of Regulation (EU) No 1095/2010. ”; (3) The following Article 4a is added : “Article 4a Financial counterparties subject to a clearing obligation 1. A financial counterparty taking positions in OTC derivative contracts may calculate, annually, its aggregate month-end average position for the previous 12 months ▌in accordance with paragraph 3. Where the financial counterparty does not calculate its position or the result of that calculation exceeds the clearing thresholds specified pursuant to Article 10(4)(b), the financial counterparty shall: (a) immediately notify ESMA and the relevant competent authority thereof; (b) be subject to the clearing obligation referred to in Article 4 for future OTC derivative contracts, irrespective of the asset class or asset classes for which the clearing threshold has been exceeded; and (c) clear the contracts referred to in point (b) within four months of becoming subject to the clearing obligation. 2. A financial counterparty that has become subject to the clearing obligation in accordance with paragraph 1 and subsequently demonstrates to the relevant competent authority that its aggregate month-end average position for the previous 12 months ▌no longer exceeds the clearing threshold referred to in paragraph 1, shall no longer be subject to the clearing obligation set out in Article 4. 2a. Where a previously exempt financial counterparty becomes subject to the clearing obligation in accordance with paragraph 1, it shall clear its OTC derivative contracts within four months of becoming subject to that clearing obligation. 3. In calculating the positions referred to in paragraph 1, the financial counterparty shall include all OTC derivative contracts entered into by that financial counterparty or entered into by other entities within the group to which that financial counterparty belongs.”; (4) In Article 5(2), point (c) is deleted; (4a) In Article 6, paragraph 2, after point d the following point is added: “ (da) within each class of OTC derivatives referred to in point (d) , the details of the contract types for which relevant CCPs have been authorised to clear and the date at which those CCPs have become authorised to clear those contracts ;”; (5) In Article 6(2), point (e) is deleted; (6) The following Article 6b is added : “Article 6b Suspension of clearing obligation in situations other than resolution 1. In circumstances other than those referred to in Article 6a(1), ESMA may request that the Commission temporarily suspend the clearing obligation referred to in Article 4(1) for a specific class of OTC derivative or for a specific type of counterparty where one of the following conditions is met: (a) the class of OTC derivative is no longer suitable for central clearing on the basis of the criteria referred to in the first subparagraph of paragraph 4 and in paragraph 5 of Article 5; (b) a CCP is likely to cease clearing that specific class of OTC derivative and no other CCP is able to clear that specific class of OTC derivative without interruption; (c) the suspension of the clearing obligation for a specific class of OTC derivative or for a specific type of counterparty is necessary to avoid or address a serious threat to financial stability in the Union and that suspension is proportionate to that aim. For the purposes of point (c) of the first subparagraph, ESMA shall consult the ESRB prior to the request referred to therein. Where ESMA requests that the Commission temporarily suspend the clearing obligation referred to in Article 4(1), it shall provide reasons and submit evidence that at least one of the conditions laid down in the first subparagraph is fulfilled. The Commission shall without delay inform the European Parliament and the Council of ESMA's request. 1a. A suspension request by ESMA as referred in paragraph 1 of this Article may be requested by a competent authority designated in accordance with Article 22. Where the competent authority requests that ESMA submit a suspension request, it shall provide reasons and submit evidence that at least one of the conditions laid down in the first subparagraph of paragraph 1 is fulfilled. ESMA shall, within 48 hours of receipt of a request by the competent authority and based on the reasons and evidence provided by the competent authority, either request that the Commission suspend the clearing obligation for the specific class of OTC derivative or for the specific type of counterparty referred to in paragraph 1, or reject the competent authority’s request. ESMA shall inform the competent authority concerned of its decision and provide a detailed reasoning explaining it. 2. The request referred to in paragraph 1 shall not be made public. 3. The Commission shall, within 48 hours of the request referred to in paragraph 1 and based on the reasons and evidence provided by ESMA, either suspend the clearing obligation for the specific class of OTC derivative or for the specific type of counterparty referred to in paragraph 1, or reject the requested suspension. The Commission shall inform ESMA of its decision and shall provide a detailed reasoning explaining it.The Commission shall thereafter transmit that information without delay to the European Parliament and the Council. 4. The Commission’s decision to suspend the clearing obligation ▌shall be published in the Official Journal of the European Union, on the Commission’s website and in the public register referred to in Article 6. 5. A suspension of the clearing obligation pursuant to this Article shall be valid for a period not exceeding one month from the date of the publication of that suspension in the Official Journal of the European Union. 6. Where the grounds for the suspension continue to apply , the Commission, after consulting ESMA and the ESRB , may extend the suspension referred to in paragraph 5 for one or more periods of one month, which shall not cumulatively exceed 12 months from the end of the initial suspension period. An extension of the suspension shall be published in accordance with Article 4. For the purposes of the first subparagraph, the Commission shall notify ESMA and inform the European Parliament and the Council of its intention to extend a suspension of the clearing obligation. ESMA shall issue an opinion on the extension of the suspension within 48 hours of that notification.”; (7) Article 9 is amended as follows: (a) paragraph 1 is replaced by the following: “1. Financial counterparties, non-financial counterparties that meet the conditions referred to in the second subparagraph of Article 10(1) and CCPs shall ensure that the details of any derivative contract they have concluded and of any modification or termination of the contract are reported in accordance with paragraph 1a to a trade repository registered in accordance with Article 55 or recognised in accordance with Article 77. The details shall be reported no later than the working day following the conclusion, modification or termination of the contract. The reporting obligation shall apply to derivative contracts which ▌were entered into on or after 12 February 2014. Notwithstanding Article 3, the reporting obligation shall not apply to OTC derivative contracts within the same group where at least one of the counterparties is a non-financial counterparty or would be qualified as a non-financial counterparty if it were established in the Union, provided that: (a) both counterparties are included in the same consolidation on a full basis; (b) both counterparties are subject to appropriate centralised risk evaluation, measurement and control procedures; and (c) the parent undertaking is not a financial counterparty .”; (b) the following paragraphs 1a and 1b are inserted: “1a. The details of derivative contracts referred to in paragraph 1 shall be reported as follows: ▌ (b) ▌the details of OTC derivative contracts concluded between a financial counterparty and a non-financial counterparty that do not meet the conditions referred to in the second subparagraph of Article 10(1) shall be reported as follows: (i) financial counterparties shall be solely responsible and legally liable for reporting a single data set , as well as for ensuring the accuracy of the details reported. To ensure that the financial counterparty has all the data needed to fulfil the reporting obligation, the non-financial counterparty shall provide the financial counterparty with the details relating to the OTC derivative contracts concluded between them, which the financial counterparty cannot be reasonably expected to possess . The non-financial counterparty is responsible for ensuring that those details are accurate. (ii) notwithstanding point (i), non-financial counterparties who have already invested to put in place a reporting system may choose to report the details of their OTC derivative contracts with financial counterparties to a trade repository. In that case, the non-financial counterparties shall inform the financial counterparties with which they have concluded OTC derivative contracts of their decision beforehand. The responsibility and legal liability for reporting and for ensuring the accuracy of those details shall in this situation remain with the non-financial counterparties. (ba) in the case of OTC derivative contracts concluded by a non-financial counterparty that is not subject to the conditions referred to in the second subparagraph of Article 10(1) with an entity established in a third-country that would be a financial counterparty if established in the Union, such a non-financial counterparty shall not be required to report pursuant to Article 9 and shall not be legally liable for reporting or ensuring the accuracy of the details of such OTC derivative contracts where: (i) the concerned third-country legal regime for reporting has been deemed equivalent pursuant to Article 13 and, the third-country financial counterparty has reported such information pursuant to its third-country legal regime for reporting; (ii) the concerned third-country legal regime for reporting has not been declared equivalent pursuant to Article 13, the third-country financial counterparty chooses to be subject to, as if it were a financial counterparty established in the Union, to the requirements of this Article and registers itself with ESMA. ESMA shall make make a Union-wide register of the third-country financial counterparties that choose to be subject to this Article in accordance with point (ii) publicly available on its website; (c) the management company of a UCITS shall be responsible for reporting the details of OTC derivative contracts to which that UCITS is a counterparty as well as for ensuring the accuracy of the details reported; (d) the manager of an AIF shall be responsible for reporting the details of OTC derivative contracts to which that AIF is a counterparty as well as for ensuring the accuracy of the details reported; (e) counterparties and CCPs that report OTC derivative contracts to a trade repository shall ensure that the details of their derivative contracts are reported accurately and without duplication. Counterparties and CCPs subject to the reporting obligation referred to in paragraph 1 may delegate that reporting obligation. 1b. ESMA shall develop draft regulatory technical standards specifying the details to be provided by a third-country financial counterparty for its registration with ESMA referred to in point (ba)(ii) of the first subparagraph of paragraph 1a. ESMA shall submit those draft regulatory technical standards to the Commission by ... [six months following the date of entry into force of this amending Regulation]. The Commission is empowered to supplement this Regulation by adopting the regulatory technical standards referred to in the first subparagraph in accordance with Articles 10 to 14 of Regulation (EU) No 1095/2010. ”; (c) paragraph 6 is replaced by the following: “6. To ensure uniform conditions of application of paragraphs 1 and 3, ESMA shall, in close cooperation with the ESCB , develop draft implementing technical standards specifying: (a) the data standards and formats for the information to be reported, which shall include at least the following: (i) global legal entity identifiers (‘LEIs’); (ii) international securities identification numbers (‘ISINs’); (iii) unique trade identifiers (‘UTIs’); (b) the methods and arrangements for reporting; (c) the frequency of the reports; (d) the date by which derivative contracts are to be reported, including any phase-in for contracts entered into before the reporting obligation applies. In developing those draft technical standards, ESMA shall take into account international developments and standards agreed upon at Union or global level, and their consistency with the reporting requirements laid down in Article 4 of Regulation (EU) No 2015/2365 (*1) and Article 26 of Regulation (EU) No 600/2014. ESMA shall submit those draft implementing technical standards to the Commission by [ 12 months after the entry into force of this amending Regulation]. Power is conferred on the Commission to adopt the implementing technical standards referred to in the first subparagraph in accordance with Article 15 of Regulation (EU) No 1095/2010.; (8) In Article 10, paragraphs 1 to 4 are replaced by the following: “1. A non-financial counterparty taking positions in OTC derivative contracts may calculate, annually, its aggregate month-end average position for the previous 12 months ▌in accordance with paragraph 3. Where the non-financial counterparty does not calculate its position or the result of the calculation referred to in the first subparagraph exceeds the clearing thresholds specified pursuant to paragraph 4(b), that non-financial counterparty shall: (a) immediately notify ESMA and the authority designated in accordance with paragraph 5 thereof; (b) where it has not calculated its position , be subject to the clearing obligation referred to in Article 4 for future OTC derivative contracts in all asset classes and to the requirements set out in Article 11(3) ; (ba) where the result of the calculation referred to in the first subparagraph exceeds the clearing thresholds specified pursuant to point (b) of paragraph 4, be subject to the clearing obligation referred to in Article 4 for future OTC derivative contracts in the asset class or asset classes for which the clearing threshold has been exceeded and exempted from the requirements set out in Article 11(3) in the other asset class or asset classes for which the clearing threshold has not been exceeded ; (c) clear the contracts referred to in point (b) within four months of becoming subject to the clearing obligation. 2. A non-financial counterparty that has become subject to the clearing obligation in accordance with the second subparagraph of paragraph 1 and subsequently demonstrates to the authority designated in accordance with paragraph 5 that its aggregate month-end average position for the previous 12 months ▌no longer exceeds the clearing threshold referred to in paragraph 1 shall no longer be subject to the clearing obligation set out in Article 4. 3. In calculating the positions referred to in paragraph 1, the non-financial counterparty shall include all the OTC derivative contracts entered into by the non-financial counterparty or by other non-financial entities within the group to which the non-financial counterparty belongs, which are not objectively measurable as reducing risks directly relating to the commercial activity or treasury financing activity of the non-financial counterparty or of that group. 4. In order to ensure consistent application of this Article, ESMA shall develop draft regulatory technical standards, after consulting the ESRB and other relevant authorities, specifying: (a) criteria for establishing which OTC derivative contracts are objectively measurable as reducing risks directly relating to the commercial activity or treasury financing activity referred to in paragraph 3; and (b) values of the clearing thresholds, which are determined taking into account the systemic relevance of the sum of net positions and exposures per counterparty and per class of OTC derivatives. ESMA may develop distinct clearing thresholds for financial and non-financial counterparties taking into account the interconnectedness of financial counterparties and their higher systemic risk. After conducting an open public consultation, ESMA shall submit those draft regulatory technical standards to the Commission by 30 September 2012 and shall regularly update them. Power is delegated to the Commission to adopt the regulatory technical standards referred to in the first subparagraph in accordance with Articles 10 to 14 of Regulation (EU) No 1095/2010. After consulting the ESRB and other relevant authorities, ESMA shall periodically review the thresholds referred to in point (b) and, where necessary, in particular to ensure increased participation in central clearing , propose regulatory technical standards to amend them.”; (8a) In Article 11, the following paragraph is inserted: “1a. The requirements referred to in paragraph 1 of this Article shall not apply to intragroup transactions as referred to in Article 3 where one of the counterparties is a non-financial counterparty which is not subject to the clearing obligation in accordance with the second subparagraph of Article 10(1).”; (8b) In Article 11, paragraph 3 is amended as follows: “3. Financial counterparties shall have risk-management procedures in place that require timely, accurate and appropriately segregated exchange of collateral with respect to OTC derivative contracts that are entered into on or after 16 August 2012. Non-financial counterparties as referred to in Article 10 may not apply risk-management procedures that require timely, accurate and appropriately segregated exchange of collateral with respect to OTC derivative contracts that are in the asset class or asset classes for which the clearing threshold has not been exceeded.”; (9) Paragraph 15 of Article 11 is amended as follows: (a) Point (a) is replaced by the following: “(a) the risk-management procedures, including the levels and type of collateral and segregation arrangements referred to in paragraph 3, as well as related supervisory procedures to ensure initial and ongoing validation of those risk-management procedures;”; (b) The first sentence of subparagraph 2 is replaced by the following: “The ESAs shall submit those common draft regulatory technical standards to the Commission by [12 months after the entry into force of this amending Regulation].”; (10) In Article 38, the following paragraphs 6 and 7 are added: “6. A CCP shall provide its clearing members with a simulation tool allowing them to determine the amount, on a gross basis, of additional initial margin that the CCP may require upon the clearing of a new transaction. That tool shall only be accessible on a secured access basis and the results of the simulation shall not be binding. 7. A CCP shall provide its clearing members with information on the initial margin models it uses. That information shall meet all of the following conditions: (a) it clearly explains the design of the initial margin model and how it operates; (b) it clearly describes the key assumptions and limitations of the initial margin model and the circumstances under which those assumptions are no longer valid (c) it is documented.”; (11) In Article 39, the following paragraph 11 is added: “11. Member States’ national insolvency laws shall not prevent a CCP from acting in accordance with paragraphs 5 to 7 of Article 48 with regard to the assets and positions recorded in the accounts referred to in paragraphs 2 to 5 of this Article. ”; (12) Article 56 is amended as follows: (a) paragraph 1 is replaced by the following: “1. For the purposes of Article 55(1), a trade repository shall submit either of the following to ESMA: (a) an application for registration; (b) an application for an extension of the registration where the trade repository is already registered under Chapter III of Regulation (EU) No 2015/2365.”; (b) paragraph 3 is replaced by the following: “3. To ensure a consistent application of this Article, ESMA shall develop draft regulatory technical standards specifying the following: (a) the details of the application for the registration referred to in paragraph 1(a); (b) the details of a simplified application for the extension of the registration referred to in paragraph 1(b). ESMA shall submit those draft regulatory technical standards to the Commission by [12 months after the entry into force of this amending Regulation]. Power is delegated to the Commission to adopt the regulatory technical standards referred to in the first subparagraph in accordance with Articles 10 to 14 of Regulation (EU) No 1095/2010.”; (c) paragraph 4 is replaced by the following: “4. To ensure uniform conditions of application of paragraph 1, ESMA shall develop draft implementing technical standards specifying the following: (a) the format of the application for registration referred to in paragraph 1(a); (b) the format of the application for an extension of the registration referred to in paragraph 1(b). With regard to point (b) of the first subparagraph, ESMA shall develop a simplified format. ESMA shall submit those draft implementing technical standards to the Commission by [9 months after the entry into force of this amending Regulation]. Power is conferred on the Commission to adopt the implementing technical standards referred to in the first subparagraph in accordance with Article 15 of Regulation (EU) No 1095/2010.”; (12a) In Article 62, paragraph 5 is deleted. (12b) In Article 63, paragraph 1 is replaced by the following: “1. In order to carry out its duties under this Regulation, ESMA may conduct all necessary on-site inspections at any business premises or property of the legal persons referred to in Article 61(1). Where the proper conduct and efficiency of the inspection so require, ESMA may carry out the on-site inspection without prior announcement.”; (12c) In Article 63, paragraph 2 is replaced by the following: “2. The officials and other persons authorised by ESMA to conduct an on-site inspection may enter any business premises or property of the legal persons subject to an investigation decision adopted by ESMA and shall have all the powers as referred to in Article 62(1). They shall also have the power to seal any business premises and books or records for the period of, and to the extent necessary for, the inspection.”; (12d) In Article 63, paragraph 8 is deleted. (12e) In Article 64, paragraph 4 is amended as follows: “4. When submitting the file with the findings to ESMA, the investigation officer shall notify the persons who are subject to the investigations. Such persons shall be entitled to have access to the file, subject to the legitimate interest of other persons in the protection of their business secrets. The right of access to the file shall not extend to confidential information or to ESMA’s internal preparatory documents.”; (12f) In Article 64, paragraph 8 is replaced by the following: “8. ESMA shall refer matters for criminal prosecution to the appropriate authorities for investigation and possible criminal prosecution where, in carrying out its duties under this Regulation, it finds that there are serious indications of the possible existence of facts that it knows to be liable to constitute criminal offences under the applicable law. In addition, ESMA shall refrain from imposing fines or periodic penalty payments where it is aware that a prior acquittal or conviction arising from identical fact or facts which are substantially the same has already acquired the force of res judicata as the result of criminal proceedings under national law.”; (12g) In Article 65(1), the second subparagraph is deleted. (13) Article 65(2) is amended as follows: (a) in point (a), “EUR 20 000”is replaced by “EUR 200 000”; (b) in point (b), “EUR 10 000”is replaced by “EUR 100 000”; (c) the following point (c) is added: “(c) for the infringements referred to in Section IV of Annex I, the amount of the fines shall be at least EUR 5 000 and shall not exceed EUR 10 000.”; (13a) In Article 67(1), the following subparagraph is added: “The first subparagraph shall not apply if urgent action is needed in order to prevent significant and imminent damage to the financial system or significant and imminent damage to the integrity, transparency, efficiency and orderly functioning of financial markets, including the stability or the accuracy of data reported to a trade repository. In such a case, ESMA may adopt an interim decision and shall give the persons concerned the opportunity to be heard as soon as possible after taking its decision.”; (14) In Article 72, paragraph 2 is replaced by the following: “2. The amount of a fee charged to a trade repository shall cover all reasonable administrative costs incurred by ESMA for its registration and supervision activities and be proportionate to the turnover of the trade repository concerned and the type of registration and supervision exercised.”; (15) The following Article 76a is inserted: “Article 76a Mutual direct access to data 1. Where necessary for the exercise of their duties, relevant authorities of third countries in which one or more trade repositories are established shall have direct access to information in trade repositories established in the Union, provided the Commission has adopted an implementing act in accordance with paragraph 2 to that effect. 2. Upon submission of a request by the authorities referred to in paragraph 1, the Commission may adopt implementing acts, in accordance with the examination procedure referred to in Article 86(2), determining whether the legal framework of the third country of the requesting authority fulfils all of the following conditions: (a) trade repositories established in that third country are duly authorised; (b) effective supervision of trade repositories and effective enforcement of their obligations takes place in that third country on an ongoing basis; (c) guarantees of professional secrecy exist and those guarantees are at least equivalent to those laid down in this Regulation, including the protection of business secrets shared with third parties by the authorities; (d) trade repositories authorised in that third country are subject to a legally binding and enforceable obligation to grant to the entities referred to in Article 81(3) direct and immediate access to the data.”; (16) In Article 78, the following paragraph 9 and 10 are added: “(9) A trade repository shall establish the following procedures and policies: (a) procedures for the effective reconciliation of data between trade repositories; (b) procedures to ensure the completeness and accuracy of the reported data; (c) policies for the orderly transfer of data to other trade repositories where requested by the counterparties or CCPs referred to in Article 9 or where otherwise necessary. (10) To ensure a consistent application of this Article, ESMA shall develop draft regulatory technical standards specifying: (a) the procedures for the reconciliation of data between trade repositories; (b) the procedures to be applied by the trade repository to verify the compliance by the reporting counterparty or submitting entity with the reporting requirements and to verify the completeness and accuracy of the information reported under Article 9. ESMA shall submit those draft regulatory technical standards to the Commission by ... [12 months after the entry into force of this amending Regulation]. Power is delegated to the Commission to adopt the regulatory technical standards referred to in the first subparagraph in accordance with Articles 10 to 14 of Regulation (EU) No 1095/2010.”; (17) Article 81 is amended as follows: (a) the following point (q) is added to paragraph 3: “(q) the relevant authorities of a third country in respect of which an implementing act pursuant to Article 76(a) has been adopted;”; (b) the following paragraph 3a is inserted: “3a. A trade repository shall provide counterparties and CCPs referred to in the second subparagraph of Article 9(1a) with the information reported on their behalf.”; (c) paragraph 5 is replaced by the following: “5. In order to ensure consistent application of this Article, ESMA shall, after consulting the members of the ESCB, develop draft regulatory technical standards specifying the following: (a) the information to be published or made available in accordance with paragraphs 1 and 3; (b) the frequency of publication of the information referred to in paragraph 1; (c) the operational standards required to aggregate and compare data across repositories and for the entities referred to in paragraph 3 to access that information; (d) the terms and conditions, the arrangements and the required documentation under which trade repositories grant access to the entities referred to in paragraph 3. ESMA shall submit those draft regulatory technical standards to the Commission by [ 12 months after the entry into force of this amending Regulation]. In developing those draft technical standards, ESMA shall ensure that the publication of the information referred to paragraph 1 does not reveal the identity of any party to any contract. Power is delegated to the Commission to adopt the regulatory technical standards referred to in the first subparagraph in accordance with Articles 10 to 14 of Regulation (EU) No 1095/2010.”; (18) Article 82(2) is replaced by the following: “2. The delegation of power referred to in Article 1(6), Article 4(3) Article 64(7), Article 70, Article 72(3), Article 76a and Article 85(2) shall be conferred to the Commission for an indeterminate period of time.”; (19) Article 85 is amended as follows: (a) paragraph 1 is replaced by the following: ‘1. By ... [˘three years following the date of entry into application of this amending Regulation] the Commission shall assess the application of this Regulation and prepare a general report. The Commission shall submit that report to the European Parliament and the Council, together with any appropriate proposals.’ (aa) the following paragraph inserted: “1a. By ... [three years after the date of entry into force of this amending Regulation], ESMA shall submit a report to the European Parliament, to the Council and to the Commission analysing the impact on market participants of the changes introduced by Regulation (EU) 2018/... [this amending Regulation] to the reporting regime. That report shall in particular assess the take-up and implementation of the respective provisions allowing the delegation of reporting to financial counterparties and requiring reporting of contracts by CCPs and investigate whether those new provisions have had the intended effect of reducing the reporting burden for smaller counterparties. It shall also investigate how those new provisions have affected the competition between trade repositories and whether and to what extent they have resulted in a less competitive environment and less freedom of choice for clearing members and their clients.” ; (b) paragraph 2 is replaced by the following: “2. By [one year following the date of entry into force of this amending Regulation ], and every year thereafter until ... two years following the date of entry into force of this amending Regulation], the Commission shall prepare a report assessing whether viable technical solutions have been developed for the transfer by PSAs of cash and non-cash collateral as variation margins and the need for any measures to facilitate those technical solutions. ESMA shall, by [six months following the date of entry into force of this amending Regulation], and every year thereafter until ... [two years following the date of entry into force of this amending Regulation], in cooperation with EIOPA, EBA and the ESRB, submit a report to the Commission, assessing the following: (a) whether CCPs, clearing members and PSAs have undertaken an appropriate effort and developed viable technical solutions facilitating the participation of PSAs in central clearing by posting cash and non-cash collateral as variation margins, including the implications of those solutions on market liquidity and procyclicality and their potential legal or other implications ; (b) the volume and the nature of the activity of PSAs in cleared and uncleared OTC derivatives markets, per asset class, and any related systemic risk to the financial system; (c) the consequences of PSAs fulfilling the clearing requirement on their investment strategies, including any shift in their cash and non-cash asset allocation; (d) the implications of the clearing thresholds referred to in Article 10(4) for PSAs; (e) the impact of other legal requirements on the cost differential between cleared and uncleared OTC derivative transactions, including margins requirements for uncleared derivatives and the calculation of the leverage ratio carried out pursuant to Regulation (EU) No 575/2013; (f) whether any further measures are necessary to facilitate a clearing solution for PSAs. The Commission shall adopt a delegated act in accordance with Article 82 to extend the three-year period referred to in Article 89(1) once, by two years, where it concludes that no viable technical solution has been developed and that the adverse effect of centrally clearing derivative contracts on the retirement benefits of future pensioners remains unchanged.”; (c) paragraph 3 is replaced by the following: “3. By ... [two years following the date of entry into force of this amending Regulation] ▌ the Commission shall either : (a) submit a proposal for a binding solution, other than permanent or further temporary exemptions of PSAs from the clearing obligation, if it considers that no solution has been found by stakeholders; or (b) adopt a delegated act in accordance with Article 82 to extend the two year period referred to in Article 89(1) once, by one year, only if it considers that a solution was agreed on by the stakeholders and that additional time is needed for the implementation of that solution ; or (c) allow the exemption to lapse, while encouraging stakeholders to implement their solution beforehand if it considers that a solution has been found. ” ▌ ▌ (ca) the following paragraphs are inserted: “3a. By ... [three years following the date of entry into force of this amending Regulation], the Commission shall adopt a delegated act in accordance with Article 82 to extend the three year period referred to in Article 89(1a) once, by two years, only if it considers that the small PSAs referred to in Article 89(1a) have made the necessary efforts to develop appropriate technical solutions and that the adverse effect of centrally clearing derivative contracts on the retirement benefits of pensioners remain unchanged; 3b. ESMA shall by ... [12 months after the date of entry into force of this amending Regulation] submit a report to the Commission, assessing whether the list of financial instruments that are considered highly liquid with minimal credit and market risk, in accordance with Article 47, could be extended and whether this list could include one or more money market funds authorized in accordance with in Regulation (EU) 2017/1131. ”; (e) the following paragraphs are added: “6. By ... [six months after entry into force of this amending Regulation], the Commission shall, after consulting ESMA, submit a report to the European Parliament and to the Council on the alignment of the trading obligation for derivatives under Regulation (EU) No 600/2014 with changes made under Regulation (EU) 2018 /... [this amending Regulation] to the clearing obligation for derivatives, in particular the scope of entities subject to the clearing obligation as well as the suspension mechanism. Where such an alignment is deemed necessary and appropriate, the report shall be accompanied by a legislative proposal introducing the necessary changes. 7. ESMA shall, by ... [18 months following the date of entry into force of this amending Regulation], in cooperation with EIOPA and EBA, submit a report to the Commission, assessing whether the principle of fair, reasonable, non-discriminatory and transparent commercial terms referred to in Article 4(3a) has been effective in facilitating access to clearing. The Commission shall, by ... [two years after the date of entry into force of this amending Regulation], present a report to the European Parliament and the Council assessing whether the principle of fair, reasonable, non-discriminatory and transparent commercial terms has been effective in facilitating access to clearing and proposing, where necessary, improvements to that principle. That report shall consider the findings of the report referred to in the first subparagraph and be accompanied by a legislative proposal, where appropriate. 8. By ... [12 months after the date of entry into force of this amending Regulation] the Commission shall prepare a report assessing whether trades directly resulting from post-trade risk reduction services, including portfolio compression, should be exempted from the clearing obligation referred to in Article 4(1). In this report the Commission shall take into account in particular, the extent to which they mitigate risks, in particular counterparty credit risk and operational risk, as well as the potential for circumvention of the clearing obligation and the potential to disincentive central clearing. The Commission shall submit that report to the European Parliament and the Council, together with any appropriate legislative proposals. To assist the Commission in the elaboration of the report mentioned in the first subparagraph, ESMA shall, by ... [six months after the date of entry into force of this amending Regulation], in cooperation with the ESRB, submit a report to the Commission, assessing whether trades directly resulting from post-trade risk reduction services including portfolio compression should be exempted from the clearing obligation. That report shall investigate portfolio compression and other available non-price forming post-trade risk reduction services which reduce non-market risks in derivatives portfolios without changing the market risk of the portfolios, such as rebalancing transactions. It shall also explain the purposes and functioning of such post-trade risk reduction services, the extent to which they mitigate risks, in particular counterparty credit risk and operational risk, and assess the need to clear such trades, or to exempt them from clearing, in order to manage systemic risk. It shall also assess to what extent any exemption from the clearing obligation for such services discourages central clearing and may lead to counterparties circumventing the clearing obligation. 9. Based inter alia on the findings of the Commission public consultation on fitness check on supervisory reporting published on 1 December 2017 and on the report submitted by ESMA pursuant to the second subparagraph, the Commission shall, by [12 months following the entry into force of this amending Regulation], review and report on the application of Article 9(1a). The Commission shall submit that report to the European Parliament and the Council, together with any appropriate legislative proposal. When reviewing the application of Article 9(1a), the Commission shall assess whether the obligation to report transactions under Article 26 of Regulation (EU) No 600/2014 creates unnecessary duplication of transaction reporting for non-OTC derivatives and whether the requirement to report non-OTC transactions under Article 9(1a) could be reduced without undue loss of information with a view to simplifying the reporting chains for non-OTC derivatives for all counterparties, in particular for non-financial counterparties not subject to the clearing obligation referred to in the second subparagraph of Article 10(1). ESMA shall, by ... [six months after entry into force of this amending Regulation], in cooperation with the ESRB, submit a report to the Commission, assessing the following: (a) the consistency between the reporting requirements for non-OTC derivatives under Regulation (EU) No 600/2014 and under Article 9 of this Regulation, both in terms of details of the derivatives contract reported and access to data by the relevant entities; (b) whether it is possible to align the reporting requirements for non-OTC derivatives under Regulation (EU) No 600/2014 and under Article 9 of this Regulation, both in terms of details of the derivatives contract reported and access to data by the relevant entities; and (c) the feasibility of simplifying the reporting chains for all counterparties, including all indirect clients, taking into account the need for timely reporting and the acts and measures adopted pursuant to Article 4(4) of this Regulation and Article 30(2) of Regulation (EU) No 600/2014. ” (20) In Article 89, the first subparagraph of paragraph 1 is replaced by the following: “1. Until ... [two years following the date of entry into force of this amending Regulation], the clearing obligation set out in Article 4 shall not apply to OTC derivative contracts that are objectively measurable as reducing investment risks directly relating to the financial solvency of PSAs, and to entities established to provide compensation to members of PSAs in case of a default of a PSA. PSAs, CCPs and clearing members shall make their best efforts to contribute to the development of technical solutions that facilitate the clearing of such OTC derivative contracts by PSAs. The Commission shall set up an expert group made up of representatives of PSAs, CCPs, clearing members and other relevant parties to such technical solutions to monitor their efforts and assess the progress made in the development of technical solutions that facilitate the clearing of such OTC derivative contracts by PSAs. That expert group shall meet at least every six months. The Commission shall consider the efforts made by PSAs, CCPs and clearing members when drafting its reports pursuant to the first subparagraph of Article 85(2). ”; (20a) In Article 89, the following paragraph is inserted: “ 1a. Notwithstanding paragraph 1, until ... [three years following the date of entry into force of this amending Regulation], the clearing obligation set out in Article 4 shall not apply to OTC derivative contracts that are objectively measurable as reducing investment risks directly relating to the financial solvency of the PSAs belonging to the category of small PSAs, and to entities established to provide compensation to members of those PSAs in case of a default of such a PSA. The Commission shall adopt a delegated act in accordance with Article 82 to supplement this Regulation by determining which PSAs can be considered to be small PSAs in accordance with the first subparagraph of this paragraph, taking into account that the small PSA category shall not represent more than 5 % of the OTC derivative contracts entered into by PSAs. ”; (21) Annex I is amended in accordance with the Annex to this Regulation.